Mark S Leventhal, a director of ProPhase Labs, recently acquired 204,691 shares of the company. The buys took place at $1.61 per share, on August 17, 2015. Leventhal now owns 866,671 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.61, inclusive. The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

The above information was disclo sed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

Prophase Labs Reports Financial Results - Nov. 13, 2017
ProPhase Labs Just Filed Its Quarterly Report: Note 8 – Earnings (... - Nov. 13, 2017

Auto Refresh

Feedback